ICAD Icad Inc

icad Inc is a provider of image analysis, work flow solutions and radiation therapy for early identification and treatment of cancer. The company has cancer detection and cancer therapy segments.

As of 11/26/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Health Information Services
Index country:  USA
Country of incorporation:  USA
IPO date:  08/03/2001
Outstanding shares:  25,109,380
Average volume:  203,544
Market cap:   $195,853,164
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    44934S206
ISIN:        US44934S2068
Sedol:      B83YYY6
Valuation   (See tab for details)
PE ratio:   -22.25
PB ratio:   3.88
PS ratio:   5.40
Return on equity:   -17.47%
Net income %:   -23.98%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy